BACK TO TOP
KSE100
167,563.68
1280.13
(0.77%)
KSE100PR
52,640.28
402.15
(0.77%)
ALLSHR
101,507.20
764.14
(0.76%)
KSE30
50,883.91
402.06
(0.80%)
KMI30
240,347.64
2255.60
(0.95%)
BKTI
45,348.93
267.46
(0.59%)
OGTI
33,491.07
410.41
(1.24%)
KMIALLSHR
66,162.28
544.82
(0.83%)
PSXDIV20
73,519.40
464.35
(0.64%)
UPP9
57,445.79
444.77
(0.78%)
NITPGI
43,120.57
349.84
(0.82%)
NBPPGI
47,456.53
417.56
(0.89%)
MZNPI
29,606.04
262.01
(0.89%)
JSMFI
44,956.50
634.55
(1.43%)
ACI
23,933.35
204.35
(0.86%)
JSGBKTI
66,537.44
474.94
(0.72%)
HBLTTI
17,692.00
04-12-2025
5.25
(0.03%)
MII30
21,983.68
201.26
(0.92%)
Liven Pharma Limited
PHARMACEUTICALS
Rs.51.49
0.38
(0.74%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Dec 5, 2025 9:19 AM
REG
DFC
CSF
ODL
Open
51.49
High
51.49
Low
51.49
Volume
100
CIRCUIT BREAKER
46.00 — 56.22
DAY RANGE
51.49 — 51.49
52-WEEK RANGE ^
49.00 — 242.45
Ask Price
51.48
Ask Volume
700
Bid Price
51.20
Bid Volume
300
LDCP
51.11
VAR
18.00
HAIRCUT
22.50
P/E Ratio (TTM) **
N/A
1-Year Change * ^
-8.12%
YTD Change * ^
-65.80%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Liven Pharma Limited was incorporated in Pakistan as a private Limited Company on October 21, 1991 and was converted into a public limited company on April 30, 1992 under the Companies Ordinance, 1984 (Repealed with the enactment of the Companies Act, 2017). The principal activity of the Company is the manufacturing of pharmaceuticals and allied products.

KEY PEOPLE
Kashif Hussain SiddiquieCEO
Atif Hussain SiddiqiChairman
Muhammad SaeedCompany Secretary
ADDRESS

49-Km, Multan Road, Lahore

WEBSITE

www.liven-pharma.com

REGISTRAR

F.D. Registrar Services SMC (Pvt.) Ltd., 1705,17th Floor, Saima Trade Tower A, I.I. Chundrigar Road, Karachi

AUDITOR

M/s Reanda Haroon Zakaria Aamir Salman Rizwan & Company, Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
4,790,648.50
Shares
93,040,367
Free Float
9,304,037
Free Float
10.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Nov 6, 2025Financial Results Summary for Year ended 2025 View   PDF
Nov 6, 2025Financial Result For the Year Ended June 30, 2025 View   PDF
Aug 18, 2025Transmission of quarterly Report for the period ended March 31, 2025 View   PDF
May 27, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Transmission of Quarterly Report for the Period Ended 2025-03-31 PDF
May 21, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Transmission of Half Yearly Accounts for the period ended Decemebr 31 2024 PDF
DateTitleDocument
Nov 5, 2025Notice of Annual General Meeting for the year ended June 30, 2025 View   PDF
Oct 29, 2025Board Meeting For Consideration of Annual Accounts For The Year Ended June 30, 2025. View   PDF
Sep 5, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) - Notice of Board Meeting Of Liven Pharma Limited PDF
Jul 24, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Resolution Passed at the Extra Ordinary General Meeting PDF
Jul 15, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Board Meeting PDF
DateTitleDocument
Dec 1, 2025DISPATCH OF LETTER OF RIGHTS AND CDC INTIMATION LETTER View   PDF
Dec 1, 2025SCHEDULE FOR HANDLING UNPAID RIGHTS - LIVENR View   PDF
Dec 1, 2025CREDIT OF UNPAID RIGHTS OF LIVEN INTO CDS View   PDF
Nov 28, 2025 View   PDF
Nov 28, 2025LIVEN | Liven Pharma Limited Right Issue Subscription Amount Received From Substantial Shareholders and Directors PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales127,272245,093
Profit after Taxation(584,460)41,744(12,327)(14,291)
EPS(8.37)1.04(1.02)(1.18)
Q3 2025Q2 2025Q1 2025Q3 2024
Sales14,75517,12688,910
Profit after Taxation(9,621)(9,491)147,588(2,532)
EPS(0.10)(0.10)12.17(0.21)
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)14.1125.46
Net Profit Margin (%)(459.22)17.03
EPS Growth (%)(901.72)202.3513.562.48
PEG0.010.04(1.06)(4.29)

Payouts

DateFinancial ResultsDetailsBook Closure
September 12, 2025 6:01 PM- 21.496% (R) 27/11/2025 - 27/11/2025 -

Financial Reports